YLYao Liu

Yao Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yao Liu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Betty Yuen Kwan Law

    State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, 999078, China

    1 shared publication
  • Jerome P. L. Ng

    Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China

    1 shared publication
  • Liqun Qu

    Research Institute for Marine Traditional Chinese Medicine (Qingdao Academy of Chinese Medical Sciences), The SATCM’s Key Unit of Discovering and Developing New Marine TCM Drugs, Key Laboratory of Marine Traditional Chinese Medicine in Shandong Universities, Shandong University of Traditional Chinese Medicine, Jinan, China

    1 shared publication
  • Mengyu Wang

    Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China

    1 shared publication
  • Peng Song

    Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China

    1 shared publication
  • Tao Liu

    Research Institute for Marine Traditional Chinese Medicine (Qingdao Academy of Chinese Medical Sciences), The SATCM’s Key Unit of Discovering and Developing New Marine TCM Drugs, Key Laboratory of Marine Traditional Chinese Medicine in Shandong Universities, Shandong University of Traditional Chinese Medicine, Jinan, China

    1 shared publication

Latest Publications

  • Medicinal seahorses (Hippocampus spp.) for Alzheimer’s disease within species conservation framework: an integrated review of ethnopharmacology, bioactivity, bibliometrics, and network pharmacology

    by Peng Song, Mengyu Wang, Tao Liu, Zhuoqing Zhang, Xia Ren, Yao Liu, Jerome P. L. Ng, Vincent Kam Wai Wong, Betty Yuen Kwan Law, Xianjun Fu, et al.

    Seahorses (Hippocampus spp.) have been used in traditional Chinese medicine for centuries and are now regarded as underexplored but promising marine resources for modern drug discovery. This review reassesses medicinal seahorses as a potential marine resource for identifying multi-target candidates relevant to Alzheimer’s disease (AD) by integrating taxonomy and distribution, conservation, and aquaculture status, ethnomedicinal use, chemical composition, and pharmacology, as well as bibliometric and network-pharmacology analyses. Using published surveys and global databases, we collated records indicating 16 Hippocampus species in Chinese waters and identify five pharmacopeial taxa whose dependence on fragile coastal habitats contrasts with the recent expansion of captive-breeding, tank and pond-based culture, suggesting that regulated aquaculture can supply traceable raw material and alleviate pressure on wild populations. Bibliometric mapping of Web of Science records (1979–2024) shows a shift from aquaculture and conservation towards antioxidant, anti-inflammatory, neuroprotective, and AD-related research. Across the five medicinal species, 329 reported constituents reflect substantial chemical diversity that may contribute to antioxidant, anti-inflammatory, neuroprotective, endocrine and immunomodulatory activities with potential relevance to AD-related pathophysiology. Network-pharmacology analysis links 276 structurally defined compounds to an AD-associated gene module, highlighting a core module centered on APP, JUN and PPARγ as putative mechanistic nodes. This article is based solely on published data and involves no new field collection or experimentation on wild seahorses. We propose that future work should rely on species-verified, aquaculture-derived material, rigorous chemical characterization, and quality control, AD-focused mechanistic and pharmacokinetic studies, and synthetic or biotechnological production of key constituents to support the ethically and ecologically responsible exploration of Hippocampus-based candidates relevant to AD.